Ebola and Marburg hemorrhagic fevers are acute viral diseases that often lead to severe illness and death in humans and other primates. The infections typically affect multiple organs in the body and are often accompanied by hemorrhage (bleeding). Once the virus has been transmitted from an animal host to a human, it can then spread through person-to-person contact. Researchers in the NIAID Division of Intramural Research and at the Institute’s Vaccine Research Center as well as NIAID-supported scientists in external facilities are studying all aspects of Ebola and Marburg viruses, how they spread, and how they cause disease. Investigators seek better ways to diagnose and treat Ebola and Marburg fevers, including promising work on vaccines.
Media Availability: Monkeys with Sudan ebolavirus Treated Successfully—Aug. 22, 2016
Media Availability: NIH Explores Connection Between Ebola Survival and Co-Infection with Malaria Parasites—Aug. 16, 2016
PREVAIL Treatment Trial for Men with Persistent Ebola Viral RNA in Semen Opens in Liberia—July 5, 2016
Media Availability: Cancer Drug May Treat Sepsis, Other Uncontrollable Immune Responses to Infection—April 29, 2016
Media Availability: Two-Vaccine Ebola Regimen Shows Promise in Early-Stage Clinical Trial—April 19, 2016
All Ebola and Marburg News Releases
Last Updated August 22, 2016